CYTOKINETICS INCORPORATED CYTK (NASDAQ)

$ 2.68
11/18/2008 20:09
Sponsored by
Click here!
Change: unch (unch%)
Volume: 97,113

Avg. Volume: 281346
P/E Ratio: 0
EPS (Annual): -1.19
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 49,410
Institutional Shareholders: 69.68%
Last: 2.68
Change: unch (unch%)
Prev. Close: 2.68
Open: 2.85
Day's Range: 2.44 - 2.85
52wk Range: 1.84 - 6.16
Market Value: 134,900
Beta: 2.19
12-month EPS Change: 0.00%
Total Return Last 12 Months: -39.09%
Total Return Last 3 Years: -139.77%
Total Return Last 5 Years: -83.35%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on CYTK
Alert me Subscribe

Cytokinetics cuts work force, ends cancer research

(SOUTH SAN FRANCISCO, Calif.)Biotechnology company Cytokinetics Inc. said Tuesday it will slash its work force by 29 percent and end research activities on potential cancer treatments as part of a reorganizati...READ MORE
Sep 16, 2008 8:26AM
Keywords: CYTK, AMGN, GSK

Cytokinetics to add higher dose of drug in study

(SOUTH SAN FRANCISCO, Calif.)Cytokinetics Inc. said Wednesday it will open a new portion of a midstage study involving a higher dose of its lead drug candidate for patients with varying heart conditions.READ MORE
Aug 27, 2008 10:25AM
Keywords: CYTK

Cytokinetics shares rise ahead of study data

(NEW YORK)Shares of Cytokinetics Inc. rose Tuesday after the company said it will provide additional study data on a heart failure drug under development. The stock gained 25 cents, or 5.8 p...READ MORE
Aug 26, 2008 5:18PM
Keywords: CYTK, AMGN, GSK

Movers roundup: Coach, Radian Group

Among the stock activity stories for Tuesday, Aug. 26, from AP Financial News: NEW YORK (AP)--Shares of Coach Inc. rose Tuesday after the luxury handbag and accessories maker said ...READ MORE
Aug 26, 2008 2:39PM
Keywords: COH, RDN, APC, JRCC, CYTK

CytoKinetics, GlaxoSmithKline extend research pact

(SOUTH SAN FRANCISCO, Calif.)Biotechnology company Cytokinetics Inc. said Thursday it will extend the term of a research agreement with GlaxoSmithKline PLC for another year. The partnership, which started in 2...READ MORE
Jun 19, 2008 4:43PM
Keywords: CYTK, GSK
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN INC. +9.80 56.34
GILEAD SCIENCES -3.90 45.22
CELGENE CORPORA -10.10 57.57
STEMCELLS INC. -61.50 1.13
BIOGEN IDEC INC -30.40 43.80